This work was supported by grants From the National Natural Science Foundation of China (No. 81070449), the National Science Foundation of Beijing (No. 7112139), the National Key Technology Support Program (No. 2012BA138B03), and the Capital Clinical Characteristic Application Foundation (No. Zl11107058811024).The authors thank the nursing staff for providing excellent care to the alIo-HSCT recipients.
Background AIIogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative therapy for many hematological diseases, but there are many complications following alIo-HSCT, among which neurological complic...
This work was supported by the grants from the National Natural Science Foundation of China (No. 30770911 and No. 81070449) ; the Science Foundation of Beijing City in China (No. 7112139).
Both human hereditary spherocytosis (HS) and chronic myelogenous leukemia (CML) are life threatening. Herein we have reported the case of a woman with a combined disorder of HS and CML who underwent the matched si...